Our objective was to design a polymeric micelle-based doxorubicin and lapatinib combination therapy for treating multidrug resistant (MDR) breast cancers. Poly(ethylene ...

Objective Neratinib plus capecitabine (Ner+Cap) were proved to be clinically beneficial as a third-line treatment for women with human epidermal growth factor receptor-2 (HER2) positive metastatic ...

PurposeThis study was conducted to characterize the effect of food on the relative bioavailability of lapatinib.Patients and MethodsA single 1,500-mg, ... Each patient received a single 1,500-mg oral ...

FLORHAM PARK, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT) today announced that the U.S. Food and Drug Administration (FDA) has approved Phathom’s Citizen ...

Pesutto is on the hook for legal costs after being found to have defamed Deeming. Now she’s intending to sue Pesutto’s backers, including key Liberal Party figures.

OnePlus Pad 3: one-minute review. As someone who has sworn by iPads and iPadOS for over a decade now, consider me pleasantly surprised to discover just how much fun it is to use the OnePlus Pad 3.

In some cases, the tablets were being used to conduct “criminal enterprise activity” within state prisons after inmates rigged their tablets with contraband Wi-Fi sticks to access the internet ...

Amneal recalls 3 lots of a generic antibiotic after black spots found on tablets By Kevin Dunleavy Jun 5, 2025 10:15am Amneal Amneal Pharmaceuticals recall FDA recall ...

The 13.2in successor to the OnePlus Pad 2 arrives at $699/£529-£599/€599 depending on storage capacity, making it easier on the wallet than the similarly-sized Samsung Galaxy Tab S10 FE+ – and ...

But the OnePlus Pad 3 has proven to be the best balance of price and features you can get in Android tablets, if not all tablets, right now. And I can't wait to tell you why. OnePlus Pad 3: Specs ...

The OnePlus Pad 3 packs an impressive display, a powerful processor, and intuitive software into a thin and light design for an impressive competitor to Samsung's Galaxy tablet line.